Post by
Duster340 on Nov 06, 2023 1:15pm
Waiting for the news release
will it be on wednesday again? and then earnings report next week. i do not thing there will be much more upside before some profit taking, maybe a small pop this week after the news and then i think there will be some selling. i am a little nervous about the earnings report, maybe a surprise on raising money bought deal or reverse split. this is when investors usually get hit with dillution is when a stock moves higher, perfect opportunity for the company to raise cash for sure they will want to do it before P2 results in case of another set back which would be the end of antibe. however if they are cashed up they survive and can move on to there next drug and continue to collect a pay-cheque. i got a itchy sell finger lol
glta
Comment by
InTheKnight on Nov 06, 2023 4:20pm
On the contrary, I think it will continue to run up and will surpass previous highs since the new formulation is significantly de-risked. You're already seeing some institutional buying as they are coming back for a second run. My itchy buy fingers will buy your shares if you want. lol. Good luck to all and let's ride this wave to the bank.
Comment by
MrMugsy on Nov 06, 2023 5:56pm
Well ... if DILIsym means anything ... sure looks like it's derisked ... and ... with 15+ years patent life. DILIsym to help create a chronic path - with greater confidence now. Just give me a new molecule by mid-November and I'll be quite content. Where I wanted to be in 2023 - but - expected the Nuance ordeal to be over by now. Fingers crossed !!!
Comment by
Harper75 on Nov 07, 2023 1:44am
Are you thinking there may be a surprise Christmas present tackling both acute and chronic?? Could that be possible at this late stage...???